Floatz logo

Repository Corticotropin

Multiple Sclerosis (MS)

The University of Texas Health Science Center, HoustonPhase 4 / ApprovedDormant
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
89/ 100

Competitive context

183 Active assets in the Multiple Sclerosis (MS) cohort.

Asset / SponsorPhaseRating
Teriflunomide
Sanofi
Phase 4BBB
Ocrevus
Polpharma Biologics International AG
Phase 4BBB
Cladribine
University Hospital, Strasbourg, France
Phase 4BBB
Fampridine
MGH Institute of Health Professions
Phase 4BBB
Nabiximols
Jazz Pharmaceuticals
Phase 4BBB

View all 50 →

Same molecule, other indications

Repository Corticotropin is also rated in:

multiple sclerosisDormant
B
Indicative ·
62 / 100
View asset →
migraine disorderDormant
B
Indicative ·
57 / 100
View asset →
amyotrophic lateral sclerosisDormant
CCC
Indicative ·
54 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →